Spots Global Cancer Trial Database for toremifene
Every month we try and update this database with for toremifene cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00020735 | Prostate Cancer | toremifene conventional su... neoadjuvant the... | 18 Years - 120 Years | University of Pittsburgh | |
| Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer | NCT00010322 | Breast Cancer | atamestane toremifene | 18 Years - | Intarcia Therapeutics | |
| Toremifene in Treating Patients With Desmoid Tumors | NCT00002595 | Desmoid Tumor | toremifene conventional su... | 16 Years - | National Cancer Institute (NCI) | |
| Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study | NCT05801705 | Hormone-recepto... Premenopausal B... Breast Cancer P... Ovarian Functio... | Aromatase inhib... ovarian functio... Tamoxifen toremifene | 18 Years - 60 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00097344 | Breast Neoplasm... Neoplasms, Horm... | Atamestane Toremifene Letrozole Aromatase inhib... Estrogen recept... Hormone therapy Endocrine thera... Antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer | NCT01214291 | Risk of Bone Fr... | Toremifene | 50 Years - 80 Years | GTx | |
| Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study | NCT05801705 | Hormone-recepto... Premenopausal B... Breast Cancer P... Ovarian Functio... | Aromatase inhib... ovarian functio... Tamoxifen toremifene | 18 Years - 60 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer | NCT02506790 | Breast Cancer | metformin Melatonin Toremifene | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
| Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer | NCT01214291 | Risk of Bone Fr... | Toremifene | 50 Years - 80 Years | GTx | |
| Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer | NCT02344940 | Breast Cancer | Toremifene Tamoxifen | 18 Years - | Shanghai Jiao Tong University School of Medicine | |
| Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00020735 | Prostate Cancer | toremifene conventional su... neoadjuvant the... | 18 Years - 120 Years | University of Pittsburgh | |
| Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer | NCT02506790 | Breast Cancer | metformin Melatonin Toremifene | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
| Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer | NCT02097459 | Breast Cancer | Anastrozole Tamoxifen Toremifene | 45 Years - 55 Years | Peking Union Medical College Hospital | |
| Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea | NCT02132390 | Breast Cancer Chemotherapy In... Ovarian Functio... | Goserelin Toremifene | 18 Years - 45 Years | Peking Union Medical College Hospital | |
| Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets | NCT02353429 | Desmoid Type-fi... | Toremifene | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea | NCT02132390 | Breast Cancer Chemotherapy In... Ovarian Functio... | Goserelin Toremifene | 18 Years - 45 Years | Peking Union Medical College Hospital | |
| Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer | NCT00010322 | Breast Cancer | atamestane toremifene | 18 Years - | Intarcia Therapeutics | |
| Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer | NCT00010322 | Breast Cancer | atamestane toremifene | 18 Years - | Intarcia Therapeutics | |
| Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) | NCT05891093 | Breast Cancer | Fluzoparib Anastrozole Letrozole Exemestane Tamoxifen Toremifene Abemaciclib LHRH agonist | 18 Years - 70 Years | Fudan University | |
| Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast | NCT04666805 | Breast Cancer | Tamoxifen Toremifene Anastrozole Letrozole Exemestane | 18 Years - 85 Years | First Hospital of China Medical University | |
| Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets | NCT02353429 | Desmoid Type-fi... | Toremifene | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer | NCT00002529 | Breast Cancer | cyclophosphamid... doxorubicin hyd... epirubicin hydr... tamoxifen citra... toremifene | - 70 Years | ETOP IBCSG Partners Foundation | |
| Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer | NCT03351062 | Breast Cancer F... | Tamoxifen Toremifene | 18 Years - 50 Years | Chinese Anti-Cancer Association | |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00097344 | Breast Neoplasm... Neoplasms, Horm... | Atamestane Toremifene Letrozole Aromatase inhib... Estrogen recept... Hormone therapy Endocrine thera... Antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00044291 | Breast Neoplasm... Neoplasms, Horm... | atamestane toremifene letrozole aromatase inhib... hormone therapy endocrine thera... antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
| Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer | NCT02344940 | Breast Cancer | Toremifene Tamoxifen | 18 Years - | Shanghai Jiao Tong University School of Medicine | |
| Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer | NCT02344940 | Breast Cancer | Toremifene Tamoxifen | 18 Years - | Shanghai Jiao Tong University School of Medicine | |
| Toremifene in Treating Patients With Ovarian Cancer | NCT00003865 | Ovarian Cancer | toremifene | 18 Years - 120 Years | George Washington University | |
| Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer | NCT00002529 | Breast Cancer | cyclophosphamid... doxorubicin hyd... epirubicin hydr... tamoxifen citra... toremifene | - 70 Years | ETOP IBCSG Partners Foundation | |
| Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene | NCT01072318 | Breast Cancer | Letrozole | - | Korean Breast Cancer Study Group | |
| Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer | NCT00267553 | Breast Neoplasm... Neoplasms, Horm... | Atamestane toremifene letrozole | 18 Years - | Intarcia Therapeutics | |
| Toremifene in Treating Patients With Desmoid Tumors | NCT00002595 | Desmoid Tumor | toremifene conventional su... | 16 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
